For pharmaceuticals and life sciences organisations, an enhanced cybersecurity programme is a priority amid rapidly rising risks to employee and patient data, intellectual property, clinical trials results and information generated by health-monitoring devices. To address these threats and improve cybersecurity, many are implementing cloud-based cybersecurity and granular access control. They are also addressing the human aspects of security by hiring a Chief Information Security Officer (CISO) and elevating Board involvement in cybersecurity.
© 2015 - Sat May 30 10:54:09 UTC 2020 PwC. PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.